# Tacrolimus for the Treatment of Superficial Kaposiform Hemangioendothelioma and Tufted Angioma

> **NCT04056962** · PHASE2 · RECRUITING · sponsor: **West China Hospital** · enrollment: 50 (estimated)

## Conditions studied

- Tacrolimus, Kaposiform Hemangioendothelioma, Tufted Angioma

## Interventions

- **DRUG:** Tacrolimus ointment

## Key facts

- **NCT ID:** NCT04056962
- **Lead sponsor:** West China Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2019-09-01
- **Primary completion:** 2024-08-30
- **Final completion:** 2024-10-28
- **Target enrollment:** 50 (ESTIMATED)
- **Last updated:** 2024-05-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04056962

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04056962, "Tacrolimus for the Treatment of Superficial Kaposiform Hemangioendothelioma and Tufted Angioma". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT04056962. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*